Trond Løvli is an experienced drug development chemist with more than 17 years’ background from the health care- and pharmaceutical industry. Løvli joined the mother company G&T Septech as Business development Manager in 2010 and as Head of Development in the daughter company Extraction Technology Norway in 2013. Løvli has key experience in project lead heading international co-operated drug development projects. This includes experience in regulatory compliance such as GMP, GLP and ISO. Løvli is also experienced in Intellectual property Rights (IPR) work and business intelligence related to IPR.
Trond Løvli gained his MSc. degree in synthetic organic chemistry from the University of Oslo in 1993.
